MercadoLibre walks into its June 9 earnings report carrying a 12% loss over the past month — and a wall of analyst target-price cuts that still leaves the stock trading well below where most of the Street expects it to end up.
The analyst picture is one of managed retreat rather than panic. Since the Q4 print in early May, every major firm covering MELI trimmed its target. Morgan Stanley cut from $2,600 to $2,450 while holding its Overweight rating. Barclays moved from $2,500 to $2,300, also staying positive. JPMorgan lowered its target from $2,100 to $1,900 at Neutral. Citigroup made the most pointed move, downgrading to Neutral and cutting its target from $2,200 to $1,950. BTIG, the most recently active, reiterated its Buy and held its $2,150 target on June 2. The consensus remains firmly "buy," with a mean target near $2,217 — roughly 38% above where the stock trades today at $1,607. That gap reflects genuine long-term conviction, but it also embeds a recovery thesis that has yet to find traction in the price.
The bull case rests on structural dominance. MercadoLibre holds more than 45% e-commerce share in Brazil, and its fintech arm continues to expand credit, payments, and cross-border trade capabilities. The forward EPS growth trajectory ranks in the 84th percentile of the universe, and the composite stock score of 70 reflects a business that screens well on growth and quality despite near-term earnings momentum that has turned negative. Bears, however, point to exactly that momentum reversal — EPS estimates are decelerating over both 30- and 90-day windows — alongside persistent concerns about margin compression from heavy investment spending. The Q4 reaction underscored the risk: the stock fell more than 11% on the day after that report and shed nearly 13% over the following five sessions, as margin guidance disappointed.
Lending-market signals offer little drama as a counterpoint. Short interest is negligible at just under 2% of the free float, and it has drifted lower over the past week. Borrow availability is vast — over 9,000% of outstanding short interest — meaning there is no squeeze dynamic in the setup whatsoever. Cost to borrow remains near 0.5%, a fraction of any threshold that would signal real conviction from short sellers. Options positioning is equally neutral: the put/call ratio of 0.87 is marginally below its 20-day average, showing no unusual hedging demand ahead of the print. One signal that stands out slightly is a recent director purchase — independent director Alejandro Aguzin bought just over $990,000 worth of shares on May 22 at around $1,655, a modest but timely vote of confidence near the lows.
The June 9 print is less a test of whether MercadoLibre is growing — that remains beyond reasonable dispute — and more a test of whether management can show a credible path to margin recovery that justifies a stock now trading at a third below where the Street wants to own it.
See the live data behind this article on ORTEX.
Open MELI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
